NCT03532815

Brief Summary

Cardiovascular disease (CVD) remains the major cause of mortality globally. Applying a comprehensive interventional program based on the individual's risk may reduce the incidence and complications of CVD; thus, helping to decrease the burden on the healthcare system. This study compared the effects of a 3-month intervention involving lifestyle modification and physical activity with standard care in women ≥30 years having a moderate-to-high risk of CVD, with respect to improving physical activity and cardiovascular disease risk factors at the National Guard Residential City in Jeddah, Saudi Arabia, in 2015. The effects of this community-based lifestyle program were assessed through a randomized controlled trial. Women in the intervention group (n=31) received health education, exercise training, and diet counselling as individuals and in groups according to the participant's risk. Women in the control group (n=28) received one health education session at the screening site. The Framingham risk score (FRS) was calculated at baseline and at 3 months for both groups. The mean participant age was 42±8 years.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable cardiovascular-diseases

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

December 6, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

May 22, 2018

Completed
Last Updated

November 6, 2019

Status Verified

November 1, 2019

Enrollment Period

7 months

First QC Date

December 6, 2017

Last Update Submit

November 4, 2019

Conditions

Keywords

Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Framingham Risk Scores Reduction

    The proportion of individuals with moderate Framingham risk scores (FRS) reducing their risk by 10% and the proportion of individuals with high (FRS) reducing their risk by 25% using the Framingham risk score. It consists of six point scores including age, total cholesterol, smoking status, HDL level, diabetes status, systolic Blood Pressure and Treatment Status. The sum of these points will result in an estimate of the 10-Year risk of developing cardiovascular event and for risk categorization of low (\< 10% FRS), moderate (10%-19% FRS), or high risk (≥ 20% FRS).

    3 months

Secondary Outcomes (1)

  • Framingham Risk Category Changes

    3 months

Study Arms (2)

Lifestyle Modification group

ACTIVE COMPARATOR
Behavioral: Lifestyle Modification

Control group

NO INTERVENTION

Interventions

Lifestyle Modification group

Eligibility Criteria

Age30 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged ≥ 30 years.
  • The participants must be at moderate to high-risk of CVD according to FRS.

You may not qualify if:

  • Women aged \< 30 years.
  • Women aged ≥ 30 years with low risk of CVD according to FRS.
  • Pregnant women.
  • Female patients diagnosed with CVD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Cox JL, Vallis TM, Pfammatter A, Szpilfogel C, Carr B, O'Neill BJ. A novel approach to cardiovascular health by optimizing risk management (ANCHOR): behavioural modification in primary care effectively reduces global risk. Can J Cardiol. 2013 Nov;29(11):1400-7. doi: 10.1016/j.cjca.2013.03.007. Epub 2013 Jun 21.

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Jumana Khouja, MD, SBCM

    KAIMRC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Consultant

Study Record Dates

First Submitted

December 6, 2017

First Posted

May 22, 2018

Study Start

January 1, 2015

Primary Completion

August 1, 2015

Study Completion

September 1, 2015

Last Updated

November 6, 2019

Record last verified: 2019-11